Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a new revision of the page content.
    Difference
    0.1%
    Check dated 2026-06-27T07:50:04.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now includes Melanoma as a topic and a related topics section featuring MedlinePlus Genetics, expanding cross-linking to melanoma and genetics resources.
    Difference
    0.2%
    Check dated 2026-06-20T08:50:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now indicates recruitment has ended ('No longer looking for participants') and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), while some headings (Intervention / Treatment) are removed or renamed, indicating a reorganization of the study details.
    Difference
    0.6%
    Check dated 2026-06-13T05:20:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The revision label updated from v3.5.4 to v3.5.5. This indicates a minor platform update rather than changes to the study content or data.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:30.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic on the page. A MedlinePlus Genetics cross-reference is now included to link users with genetics-related information about melanoma.
    Difference
    0.2%
    Check dated 2026-05-29T18:44:02.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The Melanoma keyword, the 'related topics' header, and the MedlinePlus Genetics link are removed from the page's related resources area, reducing cross-links to topic resources.
    Difference
    0.2%
    Check dated 2026-05-22T11:40:20.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.